Evaquik 1mg 10 Tablets

babies: it is not applicable. lactating mothers: it is unsafe to take this medicine during breastfeeding.
limited human studies suggest that the drug may get into the milk and cause harm to the baby. please consult your doctor before using this medicine.
pregnancy: it is unsafe to take this medicine during pregnancy. human studies have shown harmful effects on the baby.
please consult your doctor before taking this medicine. alcohol: please consult your doctor before taking this medicine.
driving: evaquik tablet may cause dizziness and tiredness, which could affect your ability to drive. do not drive if you experience these symptoms.
kidney: evaquik tablets should be used with caution in patients with severe kidney disease. dose adjustment is required.
please consult your doctor before using this medicine. liver: evaquik tablets should be used with caution in patients with severe liver disease.
dose adjustment is required. please consult your doctor before using this medicine.
.

headache nausea diarrhea abdominal pain.

evaquik tablet belongs to the class serotonin receptor agonist used in the treatment of constipation. it works by stimulating the release of a chemical messenger that increases the motility of the intestine and treats constipation effectively..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• take this medicine with or without food at a fixed to get better results. • if you experience headache, nausea, abdominal pain, and diarrhoea for a long period, inform your doctor.
• take this medicine as prescribed by your doctor. • do not stop taking this medicine too early; if you stop, your symptoms may become worsen.
• inform your doctor if your constipation has not improved even after four weeks of taking this medication..

• evaquik + atropine: concurrent use may lead to a decrease in the therapeutic effect of evaquik • evaquik + benztropine: concurrent use may lead to a decrease in the therapeutic effect of evaquik • evaquik + diphenhydramine: concurrent use may lead to a decrease in the therapeutic effect of evaquik • evaquik + erdafitinab: concurrent use may lead to an increase in the therapeutic effect of evaquik • evaquik + flavoxate: concurrent use may lead to a decrease in the therapeutic effect of evaquik • evaquik + hyoscyamine: concurrent use may lead to a decrease in the therapeutic effect of evaquik.